CT-300

N/A

Report date: 2025/01/26 18:14:49
NME

Base Information

Drug NameCT-300
Drug Alias NamePRMT5 inhibitorcheckpoint control modulators (Celleron Therapeutics)PRMT inhibitors (Celleron)CT-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE2F transcription factors stimulantsProtein arginine methyltransferase 5 inhibitors
TargetsE2F transcription factorsProtein arginine methyltransferase 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelleron Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCelleron Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A